BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 8365099)

  • 1. Severe lipoatrophy with human insulin: successfully treated by CSII.
    Chantelau E; Reuter M; Schotes S; Starke AA
    Diabet Med; 1993 Jul; 10(6):580-1. PubMed ID: 8365099
    [No Abstract]   [Full Text] [Related]  

  • 2. Human insulin and lipoatrophy.
    Page MD; Bodansky HJ
    Diabet Med; 1992 Oct; 9(8):779. PubMed ID: 1395476
    [No Abstract]   [Full Text] [Related]  

  • 3. A case of lipoatrophy with human insulin-therapy.
    Chantelau E; Reuter M; Schotes S; Starke AA
    Exp Clin Endocrinol; 1993; 101(3):194-6. PubMed ID: 8223992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipoatrophy with human insulin.
    Jaap AJ; Horn HM; Tidman MJ; Walker JD
    Diabetes Care; 1996 Nov; 19(11):1289-90. PubMed ID: 8908398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipoatrophy induced by recombinant human insulin injection.
    Murao S; Hirata K; Ishida T; Takahara J
    Intern Med; 1998 Dec; 37(12):1031-3. PubMed ID: 9932635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A case of lipoatrophy with insulin detemir.
    Del Olmo MI; Campos V; Abellán P; Merino-Torres JF; Piñón F
    Diabetes Res Clin Pract; 2008 Apr; 80(1):e20-1. PubMed ID: 18281121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipoatrophy associated with lispro insulin in insulin pump therapy: an old complication, a new cause?
    Griffin ME; Feder A; Tamborlane WV
    Diabetes Care; 2001 Jan; 24(1):174. PubMed ID: 11194227
    [No Abstract]   [Full Text] [Related]  

  • 8. A new case of lipoatrophy with lispro insulin in insulin pump therapy: is there any insulin preparation free of complications?
    Ampudia-Blasco FJ; Hasbum B; Carmena R
    Diabetes Care; 2003 Mar; 26(3):953-4. PubMed ID: 12610070
    [No Abstract]   [Full Text] [Related]  

  • 9. Injection site lipoatrophy: a rare complication of recombinant human insulin.
    Chakraborty PP; Bhattacharjee R
    J Assoc Physicians India; 2010 Oct; 58():630. PubMed ID: 21510114
    [No Abstract]   [Full Text] [Related]  

  • 10. Intensified insulin therapy.
    Amiel SA
    Diabetes Metab Rev; 1993 Apr; 9(1):3-24. PubMed ID: 8344121
    [No Abstract]   [Full Text] [Related]  

  • 11. Continuous subcutaneous insulin infusion to resolve an allergy to human insulin.
    Näf S; Esmatjes E; Recasens M; Valero A; Halperin I; Levy I; Gomis R
    Diabetes Care; 2002 Mar; 25(3):634-5. PubMed ID: 11874967
    [No Abstract]   [Full Text] [Related]  

  • 12. Human recombinant DNA insulin-induced lipoatrophy in a patient with type 2 diabetes mellitus.
    Mu L; Goldman JM
    Endocr Pract; 2000; 6(2):151-2. PubMed ID: 11421532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Images in clinical medicine. Injection-site lipoatrophy.
    Sackey AH
    N Engl J Med; 2009 Nov; 361(19):e41. PubMed ID: 19890122
    [No Abstract]   [Full Text] [Related]  

  • 14. [Lipoatrophy after insulin injections can be treated with lipofilling].
    Lund PS; Sjøstrand H; Matzen SH
    Ugeskr Laeger; 2016 Dec; 178(49):. PubMed ID: 27959262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decrease of circulating insulin antibodies in two patients treated with continuous subcutaneous infusion of human insulin (recombinant DNA).
    Spijker AJ; Poortman J; Thijssen JH; Erkelens DW
    Diabetes Care; 1982; 5 Suppl 2():171-4. PubMed ID: 6765531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of Devices in Insulin Delivery.
    Meneghini LF; McNulty JN
    Diabetes Technol Ther; 2017 Feb; 19(2):76-78. PubMed ID: 28118052
    [No Abstract]   [Full Text] [Related]  

  • 17. Lipoatrophy in children with type 1 diabetes: an increasing incidence?
    Kordonouri O; Biester T; Schnell K; Hartmann R; Tsioli C; Fath M; Datz N; Danne T
    J Diabetes Sci Technol; 2015 Mar; 9(2):206-8. PubMed ID: 25411060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Insulin-induced lipoatrophy--caused by monocomponent insulin?].
    Gyimesi A; Iványi J
    Orv Hetil; 1989 Dec; 130(51):2751-2. PubMed ID: 2689957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipoatrophy associated with rapid-acting insulin analogues in young patients with type 1 diabetes mellitus.
    Szypowska A; Skórka A; Pańkowska E
    Pediatr Endocrinol Diabetes Metab; 2008; 14(2):117-8. PubMed ID: 18721499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distant site lipoatrophy: a rare complication of subcutaneous insulin therapy.
    Chakraborty PP; Biswas SN
    Postgrad Med J; 2016 Jan; 92(1083):57-8. PubMed ID: 26561591
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.